• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Group
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027
883.75 37 (4.41%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    861.20

  • Today’s High

    909.50

  • Open

    862.00

  • Perv Close

    846.45

  • 52W Low

    585.00

  • 52W High

    932.60

Key Indicators

  • P/E(TTM)

    38.12

  • Mar.Cap (₹Cr.)

    8,013.83

  • Div & Yield %

    0.40

  • Book Value(₹)

    218.61

  • Debt-Equity Ratio

    4.41

  • AGM Date

    22-Sep-2026

  • EPS

    23.18

  • P/E Ratio

    38.12

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    8,013.83

  • RONW (%)

    13.08

  • ROCE (%)

    16.60

Score Board

  • Equity (₹ in Cr.)

    45.34

  • BV (₹)

    218.60

  • Sales( ₹ in Cr.)

    1,797.55

  • NP (in Cr.)

    178.29

  • NP Var(%)

    -31.0

  • Div%

    70.0

  • CPS (₹)

    31.20

  • EPS (₹)

    19.70

  • Traded Value (₹ in Lakhs)

    8,012.01

  • 52 Week High

    932.60

  • 52 Week Low

    585.00

  • Price BSE

    884.0

  • Price NSE

    884.00

  • Market Capital( in Cr.)

    8,012.01

  • P/C Ratio

    28.40

  • P/E Ratio

    45.00

  • Price Vs.BV

    19.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,797.55 1,771.35 1,502.13 1,511.25 941.02 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,797.55 1,771.35 1,502.13 1,511.25 941.02 0.00
Other Income 15.32 12.80 11.01 1.28 2.51 0.00
Stock Adjustments 62.58 -47.85 23.36 91.22 32.54 0.00
Total Income 1,875.45 1,736.30 1,536.50 1,603.75 976.07 0.00
EXPENDITURE :            
Raw Materials 883.72 783.83 775.33 909.15 484.20 0.00
Power and Fuel Cost 87.88 80.19 82.92 74.22 43.43 0.00
Employee Cost 160.41 139.82 120.15 113.92 79.98 0.00
Other Manufacturing Expenses 219.02 188.62 109.26 91.11 164.69 0.00
Selling and Administration Expenses 77.85 78.30 66.55 82.93 21.46 0.00
Miscellaneous Expenses 61.14 24.51 25.13 22.80 0.01 0.00
Employee Benefit Expenses 160.41 139.82 120.15 113.92 79.98 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,490.02 1,295.27 1,179.33 1,294.14 793.78 0.00
Operating Profit 385.44 441.03 357.16 309.62 182.30 0.00
Interest 46.90 25.63 16.63 20.49 11.34 0.00
Gross Profit 338.54 415.40 340.53 289.13 170.96 0.00
Depreciation 104.30 79.06 66.01 55.77 37.23 0.00
Profit Before Tax 234.24 336.34 274.52 233.36 133.73 0.00
Current Tax 41.99 56.71 46.06 52.13 22.50 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 16.05 22.28 27.82 9.50 4.50 0.00
Reported Net Profit 176.20 257.35 200.65 171.73 106.73 0.00
Extraordinary Items -2.09 0.00 0.00 0.00 0.03 0.00
Adjusted Net Profit 178.29 257.35 200.65 171.73 106.70 0.00
Adjustment below Net Profit -1.29 -1.42 0.00 0.00 599.24 0.00
P & L Balance brought forward 1,266.28 1,042.07 859.55 705.95 -0.02 -0.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 36.21 31.72 18.13 18.13 0.00 0.00
P & L Balance carried down 1,404.97 1,266.28 1,042.07 859.55 705.95 -0.02
Dividend 0.00 0.00 0.00 18.13 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 70.00 100.00 60.00 40.00 0.00 0.00
Dividend Per Share(Rs) 3.50 5.00 3.00 2.00 0.00 0.00
Earnings Per Share-Unit Curr 19.44 28.39 22.14 18.95 4,269.05 -0.18
Earnings Per Share(Adj)-Unit Curr 19.44 28.39 22.14 18.95 - -
Book Value 218.66 203.44 178.92 158.74 49,558.52 9.07
Book Value(Adj)-Unit Curr 218.66 203.44 178.92 158.74 - -

Shareholding Pattern

  • Promoter Group

    42.86%

  • Public Share Holding

    57.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 155,737 155,737.00 155,737 155,737
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 155,737 0.17 155,737 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,101,775 5.63 5,101,775 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 25,690,092 28.33 25,690,092 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 7,915,360 8.73 7,915,360 9
Others 0 0.00 0 0
Sub Total 38,707,227 42.69 38,707,227 47
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,864 0.01 8,864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1 0.00 1 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,412,208 8.17 7,412,208 101
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,804,952 5.30 4,804,952 2
Mutual Funds / UTI 716,967 0.79 716,967 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,028,579 1.13 1,028,579 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,971,571 15.41 13,971,571 129
2] Non Institution
Bodies Corporate 2,897,566 3.20 2,897,566 1,113
Clearing Members 81,594 0.09 81,594 39
Directors of their Relatives 26,901 0.03 26,901 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,529,230 1.69 1,529,230 4,917
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,052,484 1.16 1,052,484 2,646
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,463,596 10.44 9,463,596 58
Individuals holding nominal share capital up to Rs. 1 lakh 21,720,729 23.95 21,720,729 167,409
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,492 0.02 18,492 6
Others 307,660 0.34 307,660 3
Sub Total 37,845,278 41.74 37,845,278 176,329
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 90,679,813 100.00 90,679,813 176,506

Company Background

Aarti Pharmalabs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Pharmalabs Ltd
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027

  • Incorporation Year

    2019

  • Registered Office

    Plot No 22/C/1 & 22/C/2
    1st Phase GIDC Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-22-6797 6666

  • FAX

    91-22-2565 3234

  • Chairman

    Rashesh C Gogri

  • Managing Director

  • Company Secretary

  • Auditor

    Gokhale & Sathe

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Pharmalabs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Pharma 883.55 1,812.87 1,797.55 38.50 11.11
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77